Val-Cit-PAB-MMAE |
| Catalog No.GC32799 |
Val-Cit-PAB-MMAE est un conjugué médicament-lieur pour l'ADC. Val-Cit-PAB-MMAE contient le lieur ADC (peptide Val-Cit-PAB) et un puissant inhibiteur de la tubuline MMAE. MMAE un puissant inhibiteur mitotique en inhibant la polymérisation de la tubuline.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 644981-35-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the peptide Val-Cit-PAB.
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *